# Diant Pharma Inc. — Form D

Diant Pharma Inc. of MANCHESTER, CT, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-30. The offering totals $4.8M, of which $1.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-09-30
- Form: D
- Accession: 0001949139-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.8M
- Amount sold: $1.4M
- Remaining: $3.4M
- Investors: 4
- Date of first sale: 2022-09-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460456

## Issuer

- Name: Diant Pharma Inc.
- CIK: 0001949139
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 130 UTOPIA RD. STE 12, MANCHESTER, CT, 06042
- Phone: 774-462-2227

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Diane Burgess | Director | MANCHESTER, CT |
| Antonio Costa | Director | MANCHESTER, CT |
| Diane Burgess | Executive Officer | MANCHESTER, CT |
| Antonio Costa | Executive Officer | MANCHESTER, CT |

## More

- [CIK 1949139 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1949139&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001949139-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.